Robot Patent Pack

Robot

Patent Pack (PDFs)

Research new robot inventions
Gaming Patent Pack

Gaming

Patent Pack (PDFs)

Research the latest gaming inventions
Social Network Patent Pack

Social Network

Patent Pack (PDFs)

Research new Social Network inventions
Drone Patent Pack

Drone

Patent Pack (PDFs)

Research new Drone inventions
Electric Vehicle Patent Pack

Electric Vehicle

Patent Pack (PDFs)

Research the latest Electric Vehicle inventions
Smartphone Patent Pack

Smartphone

Patent Pack (PDFs)

Research latest Smartphone inventions



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Web
  • Adobe patents
  • Amazon patents
  • Apple patents
  • Ebay patents
  • Facebook patents
  • Google patents
  • IBM patents
  • Linkedin patents
  • Microsoft patents
  • Oracle patents
  • Red Hat patents
  • Yahoo patents

    • Transportation
  • Boeing patents
  • Tesla Motors patents

    • Telecom
  • Qualcomm patents
  • Motorola patents
  • Nokia patents
  • RIMM patents

    • Electronics
  • AMD
  • Applied Materials
  • Seagate patents
  • General Electric
  • Caterpillar patents
  • Samsung
  • Wal-mart patents

    • Web & Computing
  • Cloud Computing
  • Ecommerce
  • Search patents
  • Smartphone patents
  • Social Media patents
  • Video patents
  • Website patents
  • Web Server
  • Android patents
  • Copyright patents
  • Database patents
  • Programming patents
  • Wearable Computing
  • Webcam patents
    • Robot Patent Pack

    Robot

    Patent Pack (PDFs)

    Research new robot inventions
    Gaming Patent Pack

    Gaming

    Patent Pack (PDFs)

    Research the latest gaming inventions
    Social Network Patent Pack

    Social Network

    Patent Pack (PDFs)

    Research new Social Network inventions
    Drone Patent Pack

    Drone

    Patent Pack (PDFs)

    Research new Drone inventions
    Electric Vehicle Patent Pack

    Electric Vehicle

    Patent Pack (PDFs)

    Research the latest Electric Vehicle inventions
    Smartphone Patent Pack

    Smartphone

    Patent Pack (PDFs)

    Research latest Smartphone inventions
    		  

    Signal Pharmaceuticals Llc patents

    Recent patent applications related to Signal Pharmaceuticals Llc. Signal Pharmaceuticals Llc is listed as an Agent/Assignee. Note: Signal Pharmaceuticals Llc may have other listings under different names/spellings. We're not affiliated with Signal Pharmaceuticals Llc, we're just tracking patents.

    ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Signal Pharmaceuticals Llc-related inventors
    Date Signal Pharmaceuticals Llc patents (updated weekly) - BOOKMARK this page
    03/09/17Treatment of cancer with dihydropyrazino-pyrazines
    02/16/17Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
    02/16/17Solid forms comprising 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, and a coformer, compositions and methods of use thereof
    02/16/17Methods for measurement of inhibition of c-jun n-terminal kinase in skin
    02/02/17Treatment of cancer with tor kinase inhibitors
    12/08/16Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
    11/03/16Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
    09/08/16Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
    09/01/16Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
    06/16/16Formulations of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
    06/16/16Methods for measurement of inhibition of c-jun n-terminal kinase in skin
    04/07/16Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
    02/11/16Haloaryl substituted aminopurines, compositions thereof,and methods of treatment therewith
    01/28/16Pyrazino[2,3-b]pyrazine mtor kinase inhibitors for oncology indications and diseases associated with the mtor/pi3k/akt pathway
    01/14/16Treatment of cancer with tor kinase inhibitors
    01/14/16Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof
    01/14/16Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
    12/17/15Inhibition of phosphorylation of pras40, gsk3-beta or p70s6k1 as a marker for tor kinase inhibitory activity
    11/26/15Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
    10/22/15Methods for treating cancer using tor kinase inhibitor combination therapy
    10/22/15Methods for treating cancer using tor kinase inhibitor combination therapy
    10/22/15Solid forms comprising 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, and a coformer, compositions and methods of use thereof
    10/22/15Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, and a coformer, compositions and methods of use thereof
    10/22/15Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
    09/03/15Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
    07/30/15Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
    06/25/15Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
    04/09/15Treatment of cancer characterized by gene mutations
    02/19/15Pyrazino[2,3-b]pyrazine mtor kinase inhibitors for oncology indications and diseases associated with the mtor/pi3k/akt pathway
    12/04/14Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
    10/23/14Treatment of cancer with dihydropyrazino-pyrazines
    10/23/14Treatment of cancer with dihydropyrazino-pyrazines
    10/23/14Methods for treating cancer using tor kinase inhibitor combination therapy
    10/23/14Methods for treating cancer using tor kinase inhibitor combination therapy
    10/23/14Methods for treating cancer using tor kinase inhibitor combination therapy
    10/23/14Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
    10/23/14Treatment of cancer with dihydropyrazino-pyrazines
    10/23/14Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
    10/23/14Methods for treating cancer using tor kinase inhibitor combination therapy
    07/24/14Haloaryl substituted aminopurines, compositions thereof,and methods of treatment therewith
    06/05/14Methods of synthesis and purification of heteroaryl compounds
    04/24/14Treatment of cancer with tor kinase inhibitors
    04/24/14Inhibition of phosphorylation of pras40, gsk3-beta or p70s6k1 as a marker for tor kinase inhibitory activity
    04/03/14Pharmaceutical formulations of a substituted diaminopurine
    10/31/13Pyrazino[2,3-b]pyrazine mtor kinase inhibitors for oncology indications and diseases associated with the mtor/pi3k/akt pathway
    09/19/13Treatment of cancer with tor kinase inhibitors
    09/19/13Treatment of cancer with tor kinase inhibitors
    09/19/13Treatment of cancer with tor kinase inhibitors
    09/19/13Treatment of cancer with tor kinase inhibitors
    09/19/13Methods of synthesis and purification of heteroaryl compounds
    08/29/13Methods for treating cancer using tor kinase inhibitor combination therapy
    08/29/13Haloaryl substituted aminopurines, compositions thereof,and methods of treatment therewith
    06/20/13Identification of gene expression as a predictive biomarker for lkb1 status
    06/06/13Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
    04/25/13Treatment of cancer with tor kinase inhibitors
    10/06/11Methods of treatment comprising the administration of heteroaryl compounds
    09/15/11Methods of treatment using heteroaryl compounds and compositions thereof
    09/30/10Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines
    12/17/09Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereof


    Try Digital Ocean SSD servers: 1-Click Installs in 55 seconds or less





    ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



    ###

    This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Signal Pharmaceuticals Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Signal Pharmaceuticals Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

    ###

    Freshpatents.com. Website Terms and Conditions



    ';